- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 23.06M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 29.03M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 28.41M sh |
| Shares Diluted | Q1 2026 · Sep 30, 2025 | 28.51M sh |
| Shares Diluted | Q1 2026 · Sep 30, 2025 | 28.28M sh |
| Shares Diluted | Q1 2026 · Jun 30, 2025 | 28.23M sh |
| Shares Diluted | Q1 2026 · Jun 30, 2025 | 28.16M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 28.09M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2024 | 26.91M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2023 | 21.56M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.85M |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$167.44M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$88.89M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $340.33M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $339.88M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $227.03M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $198.69M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $543.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $602.69M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $710.64M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $754.38M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $338.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $310.29M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $683.87M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $656.9M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.18B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.25B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.23B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.26B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$3.25 |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | −$10.15 |
| Eps Diluted | Q1 2026 · Sep 30, 2025 | −$4.01 |
| Eps Diluted | Q1 2026 · Sep 30, 2025 | −$8.12 |
| Eps Diluted | Q1 2026 · Jun 30, 2025 | −$1.50 |
| Eps Diluted | Q1 2026 · Jun 30, 2025 | −$4.10 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$2.61 |
| Eps Diluted | Q1 2026 · Dec 31, 2024 | −$17.31 |
| Eps Diluted | Q1 2026 · Dec 31, 2023 | −$17.33 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$3.25 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | −$10.15 |
| Eps Basic | Q1 2026 · Sep 30, 2025 | −$4.01 |
| Eps Basic | Q1 2026 · Sep 30, 2025 | −$8.12 |
| Eps Basic | Q1 2026 · Jun 30, 2025 | −$1.50 |
| Eps Basic | Q1 2026 · Jun 30, 2025 | −$4.10 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$2.61 |
| Eps Basic | Q1 2026 · Dec 31, 2024 | −$17.31 |
| Eps Basic | Q1 2026 · Dec 31, 2023 | −$17.33 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $268.52M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $167.88M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$94.39M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$73.24M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$92.72M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$79.31M |
| Revenue | Q1 2026 · Mar 31, 2026 | $311.34M |
| Revenue | Q1 2026 · Mar 31, 2025 | $137.25M |